Raptor Pharma (RPTP) Reports In-Line Q1 EPS

Raptor Pharma (NASDAQ: RPTP) reported Q1 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $27.5 million versus the consensus estimate of $27.17 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c